Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-027579
Filing Date
2014-05-05
Accepted
2014-05-05 16:34:23
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v375157_10q.htm 10-Q 576732
2 EXHIBIT 31.1 v375157_ex31-1.htm EX-31.1 9146
3 EXHIBIT 31.2 v375157_ex31-2.htm EX-31.2 8683
4 EXHIBIT 32.1 v375157_ex32-1.htm EX-32.1 4742
  Complete submission text file 0001144204-14-027579.txt   5238024

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT acur-20140331.xml EX-101.INS 787704
6 XBRL TAXONOMY EXTENSION SCHEMA acur-20140331.xsd EX-101.SCH 53430
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20140331_cal.xml EX-101.CAL 48207
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20140331_def.xml EX-101.DEF 255360
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20140331_lab.xml EX-101.LAB 360559
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20140331_pre.xml EX-101.PRE 299278
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

EIN.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10113 | Film No.: 14813914
SIC: 2834 Pharmaceutical Preparations